Southern Acids (M) Berhad Balance Sheet Health
Financial Health criteria checks 5/6
Southern Acids (M) Berhad has a total shareholder equity of MYR858.7M and total debt of MYR25.3M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are MYR1.0B and MYR153.2M respectively. Southern Acids (M) Berhad's EBIT is MYR44.7M making its interest coverage ratio 42.5. It has cash and short-term investments of MYR369.9M.
Key information
2.9%
Debt to equity ratio
RM 25.30m
Debt
Interest coverage ratio | 42.5x |
Cash | RM 369.86m |
Equity | RM 858.73m |
Total liabilities | RM 153.25m |
Total assets | RM 1.01b |
Recent financial health updates
No updates
Recent updates
Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear
Mar 03If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late
May 27The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing
Apr 19Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?
Feb 24Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture
Jan 13What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?
Dec 15Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years
Nov 24Financial Position Analysis
Short Term Liabilities: SAB's short term assets (MYR610.6M) exceed its short term liabilities (MYR117.7M).
Long Term Liabilities: SAB's short term assets (MYR610.6M) exceed its long term liabilities (MYR35.5M).
Debt to Equity History and Analysis
Debt Level: SAB has more cash than its total debt.
Reducing Debt: SAB's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Debt Coverage: SAB's debt is well covered by operating cash flow (32.8%).
Interest Coverage: SAB's interest payments on its debt are well covered by EBIT (42.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:54 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Southern Acids (M) Berhad is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yee Ping Voon | Kenanga Research |
Lee Hoe | RHB Investment Bank |